Adiposs recently participated in a US Market Validation Camp in San Francisco, organized by Swissnex San Francisco and supported by Innosuisse, together with nine other Swiss startups.
As part of the program, Andrej Babic, CEO, met with potential investors, research partners, and other members of the Bay Area biotech ecosystem. The conversations provided valuable insights into the US landscape and opportunities for collaboration as Adiposs continues to advance its ImageBAT® technology through clinical development.
The program also offered an opportunity to exchange perspectives with fellow Swiss startups and engage with the vibrant innovation community in the Bay Area. For Adiposs, it was an opportunity to build new relationships, explore potential research collaborations, and gain a deeper understanding of the US biotech ecosystem.
A big thank you to Innosuisse for supporting the program and to Swissnex San Francisco for organizing and facilitating the US Market Validation Camp. We look forward to building on the relationships and insights gained during the program.
